GO:0005786 signal recognition particle, endoplasmic reticulum targeting: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005786 describes the signal recognition particle (SRP), a 325 kDa ribonucleoprotein complex that targets nascent secretory and membrane proteins to the endoplasmic reticulum (ER) [1, 5].
• The SRP is composed of a 7S RNA and six polypeptides, with SRP54 as the central subunit that binds signal peptides and regulates translation via GTP hydrolysis [1, 5, 7].
• SRP binds to the ribosome as the signal peptide emerges, pauses translation, and delivers the ribosome-nascent chain complex to the ER membrane via the SRP receptor [1, 6, 8].
• Mutations in SRP components are linked to human diseases, including congenital disorders of glycosylation, neurodegeneration, and cancer.
• Recent studies reveal that SRP function is temporally regulated during translation and that accessory factors accelerate substrate release [2, 4].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of SRP gene function in health and disease [3, 6].
Description
The signal recognition particle (SRP) is a conserved ribonucleoprotein complex that mediates the co-translational targeting of secretory and membrane proteins to the endoplasmic reticulum (ER) [1, 5]. This process is essential for protein biogenesis, as it ensures that proteins destined for the secretory pathway are correctly delivered to the ER membrane for translocation [6, 8]. The SRP binds to hydrophobic signal peptides as they emerge from the ribosome, arresting translation and preventing premature release of the polypeptide into the cytosol [5, 7]. The SRP-ribosome complex then interacts with the SRP receptor on the ER membrane, facilitating the transfer of the nascent chain to the translocon and resuming protein synthesis [1, 8]. Defects in SRP components have been implicated in a range of human diseases, including congenital disorders of glycosylation, neurodegeneration, and cancer. Understanding the molecular mechanisms of SRP function is therefore critical for both basic cell biology and translational research.
signal recognition particle, endoplasmic reticulum targeting At A Glance
| GO ID | GO:0005786 |
|---|---|
| GO term | signal recognition particle, endoplasmic reticulum targeting |
| Ontology | cellular_component |
| Synonym | signal sequence receptor complex, SRP |
| Major function | Co-translational targeting of secretory and membrane proteins to the ER |
| Composition | 7S RNA and six polypeptides (SRP9, SRP14, SRP19, SRP54, SRP68, SRP72) |
| Molecular weight | 325 kDa |
| Key subunit | SRP54 (GTPase, signal peptide binding) |
| Conservation | Found in Mus musculus, Saccharomyces cerevisiae, Arabidopsis thaliana |
What Is GO:0005786?
GO:0005786 defines the signal recognition particle (SRP) as a 325 kDa ribonucleoprotein particle composed of a 7S RNA molecule and six different polypeptides. It binds to N-terminal signal peptides of proteins destined for the endoplasmic reticulum (ER) as they emerge from the ribosome, and also to the ribosome itself. This binding arrests translation, preventing the proteins from being released into the cytosol. The SRP-ribosome complex then diffuses to the ER, where it binds to the SRP receptor, allowing translation to resume and the growing polypeptide to pass through the translocon. Through GTP hydrolysis, the SRP-SRP receptor complex dissociates, and SRP returns to the cytosol. The 54 kDa subunit (SRP54) is the central player, containing an N-terminal GTPase domain and a C-terminal domain that binds signal peptides and SRP RNA. Examples are found in Mus musculus, Saccharomyces cerevisiae, and Arabidopsis thaliana.
Why Is signal recognition particle, endoplasmic reticulum targeting Important in Cell Biology?
The SRP is essential for the biogenesis of approximately one-third of the proteome, including secreted proteins, membrane receptors, and lysosomal enzymes [1, 6]. By coordinating translation with ER targeting, the SRP maintains protein homeostasis and prevents the accumulation of mistargeted proteins that can be toxic [3, 8]. Dysregulation of SRP components is associated with a growing list of human disorders, making it a focal point for understanding disease mechanisms and developing therapeutic interventions.
• SRP ensures correct targeting of secretory and membrane proteins, which are critical for cell signaling, immunity, and metabolism [1, 6].
• Mutations in SRP genes cause congenital disorders of glycosylation and other rare diseases.
• SRP dysfunction is linked to neurodegeneration, including amyotrophic lateral sclerosis and Alzheimer's disease.
• SRP components are overexpressed in some cancers, suggesting roles in tumor progression.
• SRP is a model system for studying RNA-protein interactions and GTPase-driven molecular switches [1, 5].
• Recent findings show that SRP activity is temporally regulated during translation, adding a layer of translational control.
• Accessory factors can accelerate substrate release from SRP, revealing new regulatory nodes.
• SRP is conserved across eukaryotes, enabling comparative studies in yeast, plants, and mammals [5, 7].
• Understanding SRP biology informs the design of biologics and therapeutic proteins that require efficient secretion.
• CRISPR screens targeting SRP genes can uncover vulnerabilities in cancer and other diseases.
What Happens During signal recognition particle, endoplasmic reticulum targeting?
Signal Peptide Recognition and Translation Arrest
In simple terms: The SRP grabs onto a newly made protein's 'zip code' and pauses its production.
As a nascent polypeptide emerges from the ribosome, a hydrophobic N-terminal signal peptide is recognized by the SRP54 subunit of the SRP [1, 5]. This binding occurs with high affinity and arrests further translation, preventing the protein from folding or being released into the cytosol [5, 7]. The SRP also interacts with the ribosome near the exit tunnel, ensuring stable engagement.
Targeting to the Endoplasmic Reticulum
In simple terms: The SRP carries the paused protein factory to the ER surface.
The SRP-ribosome-nascent chain complex diffuses to the ER membrane, where it binds to the SRP receptor (SR), a heterodimeric complex composed of SRα and SRβ [1, 6]. This interaction is mediated by GTP binding to both SRP54 and SRα, ensuring high fidelity [5, 8]. The complex then docks at the translocon (Sec61), allowing the nascent chain to be transferred into the ER lumen or membrane [1, 6].
GTP Hydrolysis and Complex Dissociation
In simple terms: The SRP lets go after burning energy, freeing the protein to finish synthesis.
GTP hydrolysis by SRP54 and SRα triggers conformational changes that dissociate the SRP from the SR and the ribosome [1, 5]. This allows translation to resume and the growing polypeptide to be co-translationally translocated through the Sec61 translocon [6, 8]. The SRP is then recycled back to the cytosol for another round of targeting [5, 7].
Temporal Regulation and Accessory Factors
In simple terms: The SRP cycle is timed precisely, and helper proteins can speed up release.
Recent studies have revealed that SRP function is temporally regulated during translation, with distinct kinetic phases of binding and release. Additionally, a factor has been identified that accelerates substrate release from the SRP, ensuring efficient recycling and preventing stalled complexes. These findings highlight layers of regulation beyond the core GTPase cycle.
Key Genes Involved in GO:0005786 signal recognition particle, endoplasmic reticulum targeting
The SRP is composed of six protein subunits and a 7S RNA, each with distinct roles in signal peptide recognition, RNA binding, and complex assembly.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SRP54 | Binds signal peptides and GTP; central subunit | Mutations cause congenital disorders; target for cancer studies |
| SRP19 | Binds 7S RNA and initiates SRP assembly | Essential for SRP integrity; studied in ribosomopathies |
| SRP68 | RNA-binding subunit; stabilizes SRP structure | Implicated in RNA processing and translation regulation |
| SRP72 | RNA-binding subunit; interacts with SRP68 | Mutations linked to bone marrow failure and leukemia |
| SRP9 | Binds Alu RNA; involved in translation arrest | Role in stress response and neurodegeneration |
| SRP14 | Partners with SRP9; modulates SRP function | Studied in ER stress and apoptosis |
| SRPRA | SRP receptor alpha subunit; GTPase | Essential for ER targeting; knockout is lethal in yeast |
| SRPRB | SRP receptor beta subunit; anchors SRα | Regulates SRP receptor localization and function |
| SEC61A1 | Core translocon channel | Mutations cause tubulointerstitial kidney disease |
| SEC61B | Translocon subunit | Involved in protein translocation fidelity |
| SEC62 | Translocon accessory factor | Linked to cancer and ER stress |
| SEC63 | Translocon accessory factor | Mutations cause polycystic liver disease |
| HSPA5 (BiP) | ER chaperone; assists translocation | Marker of ER stress; cancer target |
| DERL1 | ER-associated degradation component | Quality control of misfolded proteins |
| OST1 (ribophorin I) | Oligosaccharyltransferase subunit | Glycosylation of nascent chains |
| TRAM1 | Translocon-associated membrane protein | Facilitates translocation of certain substrates |
| RPN1 | Proteasome subunit; ER-associated | Cross-talk between ER and degradation |
How Is signal recognition particle, endoplasmic reticulum targeting Regulated?
SRP function is regulated at multiple levels. Translation of SRP components can be controlled by cellular demand for secretory capacity, and recent evidence indicates that SRP activity is temporally regulated during translation. GTP binding and hydrolysis by SRP54 and SRα provide a molecular timer for the targeting cycle [1, 5]. Accessory factors can accelerate substrate release from SRP, ensuring efficient recycling. Additionally, ER stress pathways, such as the unfolded protein response, can modulate SRP expression and activity to maintain protein homeostasis [6, 8].
signal recognition particle, endoplasmic reticulum targeting and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SRP54 | Congenital disorder of glycosylation, neutropenia | Knockout and point-mutation cell lines (HEK293, HeLa) |
| SRP72 | Bone marrow failure, leukemia | Knock-in of patient mutations in hematopoietic stem cells |
| SRP9 | Neurodegeneration, stress response | Overexpression and knockout in neuronal cell lines |
| SRPRA | ER targeting defects, cancer | Knockout in cancer cell lines (e.g., MCF7) |
| SEC61A1 | Tubulointerstitial kidney disease | Knock-in mouse models and patient-derived organoids |
SRP Mutations in Congenital Disorders
Mutations in SRP54 cause a congenital disorder of glycosylation characterized by severe developmental delay, neutropenia, and facial dysmorphism. Similarly, mutations in SRP72 are associated with familial bone marrow failure and leukemia predisposition. These disorders highlight the critical role of SRP in secretory cell function and hematopoiesis.
SRP Dysfunction in Neurodegeneration
Altered SRP function has been implicated in neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and Alzheimer's disease. Defects in co-translational ER targeting can lead to protein aggregation and neuronal toxicity, contributing to disease pathology [3, 6].
SRP in Cancer
SRP components are overexpressed in several cancers, including hepatocellular carcinoma and breast cancer, where they support the increased secretory demand of tumor cells. Targeting SRP subunits may therefore represent a therapeutic strategy, particularly in cancers with high secretory activity.
From signal recognition particle, endoplasmic reticulum targeting-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of SRP54 loss on secretory protein biogenesis? | SRP54 knockout HEK293 cells |
| How do disease-associated SRP54 mutations affect signal peptide binding? | Point-mutation knock-in cell lines |
| Can SRP72 mutations be rescued by wild-type SRP72? | Knock-in of mutant SRP72 with tagged wild-type rescue |
| Where does SRP localize during ER stress? | Tagged knock-in of SRP54 with GFP in HeLa cells |
| Does SRP overexpression enhance secretion of therapeutic proteins? | Overexpression of SRP subunits in CHO cells |
| Which genes are essential for SRP function? | Genome-wide CRISPR knockout library screening |
How to Study the signal recognition particle, endoplasmic reticulum targeting Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Translation efficiency and ribosome occupancy | Global translation changes upon SRP knockdown |
| RNA-seq | Transcript abundance and splicing | SRP gene expression profiling in disease models |
| Proteomics | Protein abundance and secretion | Secretome analysis in SRP mutants |
| Co-immunoprecipitation | Protein-protein interactions | Mapping SRP subunit interactions |
| Fluorescence microscopy | Subcellular localization and dynamics | Live imaging of SRP-ER targeting |
| CRISPR knockout screens | Gene essentiality and synthetic lethality | Identifying SRP pathway vulnerabilities |
| GTPase assays | GTP hydrolysis rates | Functional analysis of SRP54 mutants |
Ribosome Profiling (Ribo-seq)
Ribo-seq measures translation at codon resolution and can detect changes in translation efficiency of secretory proteins upon SRP perturbation. It is used to identify mRNAs whose translation is sensitive to SRP levels.
Proteomics and Secretome Analysis
Mass spectrometry-based proteomics can quantify the secretion of proteins in SRP mutant cells, revealing which substrates are most dependent on SRP [1, 6]. Secretome analysis is particularly useful for studying ER-targeting defects.
Fluorescence Imaging
Live-cell imaging of fluorescently tagged SRP subunits and ER markers allows real-time visualization of SRP trafficking and ER targeting [1, 8]. This method is valuable for studying the dynamics of SRP-ribosome interactions.
CRISPR Screens
Genome-wide CRISPR knockout screens can identify genes that are synthetic lethal with SRP mutations or that modulate SRP function. Such screens are powerful for uncovering novel regulators of ER targeting.
How CRISPR Can Be Used to Study GO:0005786 signal recognition particle, endoplasmic reticulum targeting
Knockout
CRISPR knockout of SRP genes (e.g., SRP54, SRP72) in cell lines such as HEK293 or HeLa can reveal their essentiality and impact on secretory protein biogenesis. Knockout models are used to study ER targeting defects and compensatory pathways.
Point Mutation
Introducing disease-associated point mutations (e.g., SRP54 mutations) via CRISPR base editing or homology-directed repair allows precise modeling of congenital disorders and functional dissection of SRP54 domains.
Knock-in
Knock-in of tagged SRP subunits (e.g., GFP-SRP54) enables live-cell imaging and proteomic analysis of SRP complexes. Knock-in of patient mutations into endogenous loci provides physiologically relevant disease models.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of SRP subunits can boost secretory capacity in biotechnologically relevant cells (e.g., CHO) for therapeutic protein production.
How EDITGENE Supports signal recognition particle, endoplasmic reticulum targeting Research
Researchers studying signal recognition particle, endoplasmic reticulum targeting-related genes often need to determine whether a candidate gene is causally involved in ER targeting, secretion, or disease. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for signal recognition particle, endoplasmic reticulum targeting research.
Frequently Asked Questions About signal recognition particle, endoplasmic reticulum targeting
What is GO:0005786?
GO:0005786 is the Gene Ontology term for the signal recognition particle (SRP), a ribonucleoprotein complex that targets proteins to the endoplasmic reticulum [1, 5].
What genes are involved in signal recognition particle, endoplasmic reticulum targeting?
Key genes include SRP54, SRP19, SRP68, SRP72, SRP9, SRP14, SRPRA, and SRPRB [1, 3].
What is the function of the signal recognition particle?
The SRP binds signal peptides on nascent proteins, pauses translation, and delivers the ribosome-nascent chain complex to the ER membrane for translocation [5, 7].
How does the SRP recognize signal peptides?
The SRP54 subunit binds hydrophobic N-terminal signal peptides as they emerge from the ribosome [1, 5].
What diseases are associated with SRP mutations?
Mutations in SRP54 and SRP72 cause congenital disorders of glycosylation, bone marrow failure, and leukemia predisposition.
What is the role of SRP54?
SRP54 is the central subunit that binds signal peptides and GTP, and is essential for translation arrest and ER targeting [1, 5].
How is the SRP regulated?
SRP function is regulated by GTP hydrolysis, temporal translation control, and accessory factors that accelerate substrate release [2, 4].
What methods are used to study the SRP?
Common methods include Ribo-seq, proteomics, fluorescence imaging, and CRISPR screens [1, 4, 6].
Can CRISPR be used to study SRP genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect SRP gene function.
What is the SRP receptor?
The SRP receptor (SRα/SRβ) is an ER membrane protein that binds the SRP-ribosome complex and facilitates nascent chain transfer to the translocon [1, 6].
Conclusion
The signal recognition particle (GO:0005786) is a fundamental component of the cellular machinery that ensures proper targeting of secretory and membrane proteins to the endoplasmic reticulum. Its intricate structure and regulated cycle are critical for protein homeostasis, and its dysfunction is linked to a spectrum of human diseases. Continued research using advanced CRISPR models and multi-omics approaches will further illuminate SRP biology and its therapeutic potential.
References
- 1. Hegde RS et al.. 2022. The mechanisms of integral membrane protein biogenesis.. Nat Rev Mol Cell Biol 23(2):107-124 PMID: 34556847
- 2. Wang H et al.. 2024. Identification of a factor that accelerates substrate release from the signal recognition particle.. Science 386(6725):996-1003 PMID: 39607913
- 3. Kellogg MK et al.. 2022. Signal Recognition Particle in Human Diseases.. Front Genet 13:898083 PMID: 35754847
- 4. Qian R et al.. 2025. Temporal Regulation of Signal Recognition Particle During Translation.. J Mol Biol 437(24):169482 PMID: 41075971
- 5. Walter P et al.. 1994. Signal sequence recognition and protein targeting to the endoplasmic reticulum membrane.. Annu Rev Cell Biol 10:87-119 PMID: 7888184
- 6. Pool MR. 2022. Targeting of Proteins for Translocation at the Endoplasmic Reticulum.. Int J Mol Sci 23(7) PMID: 35409131
- 7. Walter P. 1995. Signal sequence recognition and protein targeting to the endoplasmic reticulum membrane.. Harvey Lect 91:115-31 PMID: 9127989
- 8. Aviram N et al.. 2017. Targeting and translocation of proteins to the endoplasmic reticulum at a glance.. J Cell Sci 130(24):4079-4085 PMID: 29246967
